The EMA Launches new PRIority Medicines scheme - PRIME
The
European Medicines Agency has today launched the new PRIME (PRIority MEdicines)
scheme to strengthen support for medicines that target an unmet medical need.
The scheme focuses on medicines that may offer a major therapeutic advantage
over existing treatments, or benefit patients with no treatment options.
A
press
release and further information on PRIME have been published on the EMA
website, including details of how to apply.
scheme to strengthen support for medicines that target an unmet medical need. 
No comments:
Post a Comment